AI x Drugs?

Plus, Amazon's new AI Coding Tool...

In partnership with

Welcome back, AI’ers!

Today's post is 343 words, a 2-minute read.

Here’s What’s On The Menu For Today

  • 🧠 AI On My Mind

  • 🤖 FDA Approves To Approve AI

  • Amazon’s New AI Coding Tool

  • 📰 News Hot Off The Press

AI ON MY MIND

Happy Friday!

The next wave of AI companies won’t be won by engineers.

It'll be operators who know how to build systems, not systems who happen to code. The people stacking cash right now aren’t fine-tuning LLMs—they’re packaging them into offers, distribution, and onboarding flows that print.

The barrier to entry has dropped. You don’t need a Stanford CS degree. You need clear positioning, strong distribution, and a product that solves a painful problem.

That’s why technical founders are getting boxed out. Not overnight. But over time.

AI is no longer about building the tech. It’s about building with the tech.

So the question is: are you still trying to “develop,” or are you focused on shipping value?

A MESSAGE FROM OUR PARTNER

Hear why BILL S&E is #1 + earn AirPods 4

BILL is the all-in-one financial platform that simplifies managing bills, invoices, expenses, budgets, and business credit.

As a controller, you need software that works as hard as you do—that’s why BILL Spend & Expense is ranked #1 on G2’s 2025 Best Accounting & Finance Products list. New features include:

  • Assistant permissions for seamless delegation

  • Auto-freezing cards

  • Visa Signature benefit

  • API integrations for smarter scaling

Ready to see it in action and claim your AirPods 4?*

*Terms and conditions apply. See offer page for details. The BILL Divvy Card is issued by Cross River Bank, Member FDIC, and is not a deposit product.

TODAY’S TOP STORIES

FDA Considers AI Integration for Drug Development

The FDA is discussing with OpenAI about using AI for drug development and review processes.

Why it matters: Implementing AI can streamline drug evaluation, reduce costs, and potentially accelerate time-to-market for life-saving treatments. However, this raises substantial concerns over data privacy and decision reliability.

Driving the news:

- The FDA is exploring partnerships with tech companies to integrate AI technology.

- OpenAI's potential involvement could set industry standards for AI-driven drug evaluation.

Zoom in:

- The pharmaceutical sector could see significant cost reductions.

- "AI enables faster insights," says Dr. Anderson from the Medical Research Council.

Yes, but: The shift to AI requires robust data privacy measures to ensure patient data protection.

Be Smart: Embracing AI in drug research could redefine how quickly and safely new drugs reach patients, but it requires balancing innovation with ethical oversight.

The bottom line: AI in drug development could revolutionize the healthcare industry, but regulatory vigilance is crucial.

Amazon Develops AI Coding Tool 'Kiro'

Why it matters: Kiro could dramatically improve coding efficiency, saving time for developers and increasing productivity across the tech industry.

What we found: Kiro harnesses AI's capability to assist in coding tasks with multimodal features.

How it works:

- The tool can interpret and execute coding tasks from varied input forms including voice and text.

- Designed to integrate seamlessly with existing coding environments.

Yes, but: There are concerns about developer dependency on AI tools which may affect problem-solving skills.

The bottom line: If successful, Kiro promises to be a game-changer for coding efficiency, but overshot reliance on AI tools warrants caution.

TODAY’S FEATURED TOOL

🖥️ Serif AI

If you’re not using Serif yet, I don’t know what you’re waiting for.

This tool has quickly become one of my go-to time savers.

Here’s why:

Every time I check my inbox, Serif has already written replies for the emails that need a response.

All I do is review, make quick edits if needed, and hit send. That’s it. .

(Try it out →Link)

👾 Other AI Tools We Use Everyday

➡️ N8N for AI Agents - Literally use this everyday to write this newsletter (link)

➡️ Axiom AI - AI Browser automation to scrape anything on the web (link)

➡️ GummySearch - AI Reddit research (link)

Tools are sourced from our database and are not sponsored or affiliated.

OTHER NEWS YOU MAY LIKE

- Shopify released new features for its Sidekick AI assistant. Source

- Microsoft banned DeepSeek app over data security concerns. Source

- US Senate considers AI chip location-tracking bill to limit China's access. Source

- AI Giants push for reduced regulations before Congress. Source

- Alibaba's ZeroSearch slashes AI training costs by 88%. Source

- OpenAI links ChatGPT research tool to GitHub for developers. Source

- Congressional AI hearing passes without major incidents. Source

- Fidji Simo joins OpenAI. Source

SPONSOR US

Get your product in front of over 40k+ tech & AI enthusiasts

Our newsletter is read by thousands of tech professionals, investors, engineers, managers, and business owners worldwide. Get in touch to learn more.

 AI ART

Can You Spot The AI-Generated Image?

Click "Picture one", "Picture two", "Both", "None"

Login or Subscribe to participate in polls.

PROMPT OF THE DAY

Copy and paste this prompt 👇

"How can I use the most frequently asked questions about [industry/niche] to improve my website content?"

Want more prompts?

We have a database of over 8,000 of the best prompts we’ve collected, which you can access by sharing Best of AI using the link below.

THAT’S IT FOR TODAY

Until next time, stay safe.

-Best of AI Team

Remember to click to unsubscribe if you don’t want us to land in your inbox anymore.

What did you think of this issue?

Login or Subscribe to participate in polls.